Ovagen
Ovagen HomeProcessCompanyInvestorsContact
Ovagen
   
Ovagen   Ovagen
 
Ovagen Ovagen Ovagen

INTRODUCING OVAGEN...

...The world's first economically sustainable production of germ-free eggs and breeding chickens.

• Ovagen is a biotechnology company that has developed a process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry.

• Germ-free eggs are preferred as currently eggs produced from normal or SPF laying flocks can be infected with bacteria and viruses

• Germ-free eggs provide many advantages over current sources of eggs including:
A safe, biosecure, large scale, flexible and cost effective biomanufacturing platform for the production of vaccines and therapeutic proteins

• No contamination from eggs of batches of vaccines / therapeutic proteins / foods
- Leads to cost saving and greater continuity of supply of finished product
- Removes risks of production plant contamination from eggs

• GF technology enables removal of infections in conventional/SPF genetic lines (derivation and upgrading)

• GF eggs are fully compliant with USDA Memo 800.65 and European Pharmacopoeia requirements.

Ovagen Ovagen
Ovagen Ovagen
Ovagen
Events
Ovagen Ovagen Ovagen Ovagen
Ovagen Ovagen Ovagen Ovagen
Ovagen

NEW BUILDING

Ovagen

August 2008 (2500msq)
First generation germ-free flocks,
Isolators, Incubators
Laboratories
Egg processing
R&D
Head Office.

Ovagen

CONTACT

Ovagen Group Limited
Carrentrila,
Ballina,
Co. Mayo,
Ireland.

T. +353 (0)96 75579
E. info@ovagen.com

Ovagen Ovagen Ovagen Ovagen Ovagen
 
Ovagen   Ovagen
Ovagen Ovagen